SCHEMBL9699043

SCHEMBL9699043

CN(CCN(CCCO)C(=O)OCc1ccccc1)C(=O)OCc1ccccc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR6 P51684 1/20 0.59
PAX8 Q06710 1/20 0.59
F13A1 P00488 1/20 0.45
TGM2 P21980 1/20 0.45
TGM1 P22735 1/20 0.45
ALDH1A1 P00352 5/20 0.44
HDAC1 Q13547 2/20 0.42
MAPT P10636 1/20 0.42
HPGD P15428 1/20 0.42
MAPK1 P28482 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
TDP1 Q9NUW8 2/20 0.40
SLC6A2 P23975 1/20 0.40
SLC6A3 Q01959 1/20 0.40
KMT2A Q03164 1/20 0.40
SIGMAR1 Q99720 1/20 0.39
ABCB1 P08183 1/20 0.39
CHRNB2 P17787 1/20 0.39
CHRNB4 P30926 1/20 0.39
CHRNA3 P32297 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1897393 0.90 CCR6 (0.51) CCR6PAX8F13A1TGM2TGM1
SCHEMBL9698036 0.89 CCR6 (0.59) CCR6PAX8F13A1TGM2TGM1
SCHEMBL18057683 0.86 CCR6 (0.61) CCR6PAX8ALDH1A1MAPTHPGD
SCHEMBL19346032 0.86 CCR6 (0.53) CCR6PAX8F13A1TGM2TGM1
SCHEMBL7367495 0.85 ALDH1A1 (0.58) CCR6PAX8F13A1TGM2TGM1
SCHEMBL29004736 0.85 CCR6 (0.53) CCR6PAX8F13A1TGM2TGM1
SCHEMBL9698980 0.85 CCR6 (0.53) CCR6PAX8F13A1TGM2TGM1
SCHEMBL3170360 0.85 CCR6 (0.52) CCR6PAX8F13A1TGM2TGM1
SCHEMBL8424282 0.85 CCR6 (0.52) CCR6PAX8F13A1TGM2TGM1
SCHEMBL553299 0.84 ALDH1A1 (0.53) CCR6PAX8F13A1TGM2TGM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1992002521-A1 1-AZABICYCLO[3.2.0]HEPT-2-ENE-2-CARBOXYLIC ACID COMPOUNDS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1992-02-20 WO disclosed